To provide evidence about the implication of CK2 in processes affecting the stability of CFTR and/or of its Phe508del mutant which is the commonest cause of Cystic Fibrosis, advantage has been taken of the most selective cell permeable CK2 inhibitor available, CX4945. This evidence concerns the gene CFTR and cystic fibrosis.